Glargine and protamine zinc insulin have a longer duration of action and result in lower mean daily glucose concentrations than lente insulin in healthy cats

Journal of Veterinary Pharmacology and Therapeutics

Volumn 31, Issue 3, 2008, Pages 205-212

  Marshall, R D ^a,b   Rand, J S ^a   Morton, J M ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b The Cat Clinic Australia   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANINSULIN; GLUCOSE; INSULIN GLARGINE; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN; PZI VET;

ANIMAL DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CAT; CONTROLLED STUDY; DIABETES MELLITUS; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; TIME;

ANIMALS; AREA UNDER CURVE; BLOOD GLUCOSE; CATS; FEMALE; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN, LONG-ACTING; KAPLAN-MEIERS ESTIMATE; MALE; TIME FACTORS;

EID: 43549108964     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2008.00947.x     Document Type: Article

References (20)

1. Appleton, D.J., Rand, J.S., Sunvold, G.D. Priest, J. (2001) Determination of reference values for glucose tolerance, insulin tolerance and insulin sensitivity tests in clinically normal cats. American Journal of Veterinary Research, 62, 630 636.
2. Baral, R.M., Rand, J.S., Catt, M.J. Farrow, H.A. (2003) Prevalence of feline diabetes mellitus in a feline private practice. Journal of Veterinary Internal Medicine, 17, 433 434.
3. Bland, J.M. Altman, D.G. (1999) Measuring agreement in method comparison studies. Statistical Methods in Medical Research, 8, 135 160.
4. Broussard, J.D. Peterson, M.E. (1994) Comparison of two ultralente insulin preparations with protamine zinc insulin in clinically normal cats. American Journal of Veterinary Research, 55, 127 131.
5. Chinn, S. (1990) The assessment of methods of measurement. Statistics in Medicine, 9, 351 362.
6. Christopher, M.M. O'Neill, S. (2000) Effect of specimen collection and storage on blood glucose and lactate concentration in healthy, hyperthyroid, and diabetic cats. Veterinary Clinical Pathology, 29, 22 28.
7. Fonseca, V., Bell, D.S., Berger, S., Thomson, S. Mecca, T.E. (2004) A comparison of bedtime insulin glargine with bedtime Neutral protamine Hagedorn in patients with type 2 diabetes: subgroup analysis of patients taking once-daily insulin in a multicenter, randomized, parallel group study. American Journal of Medical Science, 328, 274 280.
8. Fulcher, G.R., Gilbert, R.E. Yue, D.K. (2005) Glargine is superior to NPH for improving glycated hemoglobin and fasting blood glucose levels during intensive insulin therapy. Internal Medicine Journal, 35, 536 542.
9. Gerber, H., Gerber, H., Peter, H., Ferguson, D.C. Peterson, M.E. (1994) Etiopathology of feline toxic nodular goiter. Veterinary Clinics of North America (Small Animal Practice), 24, 541 565.
10. Kaplan, E. Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistics Association, 53, 457 481.
11. Lepore, M., Pampanelli, S., Fanelli, C., Porcellati, F., Bartocci, L., Di Vincenzo, A., Cordoni, C., Costa, E., Brunetti, P. Bolli, G.B. (2000) Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes, 49, 2142 2148.
12. Link, K.R.J. (2001) Feline Diabetes: Diagnostics and Experimental Modelling [doctoral thesis]. The University of Queensland, Brisbane.
13. Lutz, T.A. Rand, J.S. (1993) Comparison of five commercial radioimmunoassay kits for the measurement of feline insulin. Research in Veterinary Science, 55, 64 69.
14. Martin, G. Rand, J.S. (2001) Pharmacology of a 40 IU/ml porcine lente insulin preparation in diabetic cats. Findings during the first week and after five or nine weeks of therapy. Journal of Feline Medicine and Surgery, 3, 23 30.
15. Moise, N.S. Riemers, T.J. (1983) Insulin therapy in cats with diabetes mellitus. Journal of the American Veterinary Medicine Association, 182, 158 164.
16. 125I-labeled insulin glargine in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites. Diabetes Care, 23, 813 819.
17. Panciera, D.L., Thomas, C.B., Eicker, S.W. Atkins, C.E. (1990) Epizootiologic patterns of diabetes mellitus in cats: 333 cases (1980-1986). Journal of the American Veterinary Medicine Association, 197, 1504 1508.
18. Rand, J.S. (1997) Understanding feline diabetes. Australian Veterinary Practitioner, 27, 17 32.
19. Rowland, M. Tozer, T.N. Eds (1989) Appendix A: assessment of area. In Clinical Pharmacokinetics: Concepts and Applications. pp. 459 471. Lea & Febiger, Philadelphia.
20. Weaver, K.E., Rozanski, E.A., Mahony, O.M., Chan, D.L. Freeman, L.M. (2006) Use of glargine and lente insulins in cats with diabetes mellitus. Journal of Veterinary Internal Medicine, 20, 234 248.